Copanlisib
Copanlisib
Copanlisib (pronounced ko-PAN-li-sib) is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is used to treat follicular lymphoma that has relapsed or did not respond to other treatments.
Etymology
The name Copanlisib is derived from the chemical structure of the drug. The "copan" part of the name is a reference to the copanlisib's chemical structure, which includes a cyclopentane ring. The "lisib" part of the name is a common suffix used for kinase inhibitors, which is the class of drugs that copanlisib belongs to.
Usage
Copanlisib is used to treat certain types of non-Hodgkin lymphoma, including follicular lymphoma and marginal zone lymphoma, that have returned or did not respond to previous treatment. It is a type of kinase inhibitor and a type of angiogenesis inhibitor.
Side Effects
Common side effects of copanlisib include high blood sugar levels, high blood pressure, diarrhea, decreased general strength and energy, swelling caused by excess fluid in body tissues, and lower respiratory tract infections.
Related Terms
- Cancer
- Follicular lymphoma
- Non-Hodgkin lymphoma
- Kinase inhibitor
- Angiogenesis inhibitor
- Cyclopentane
External links
- Medical encyclopedia article on Copanlisib
- Wikipedia's article - Copanlisib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski